Consensus Guidelines: Treatment Planning and Options

Argoff, Charles E.; Backonja, Misha-Miroslav; Belgrade, Miles J.; Bennett, Gary J.; Clark, Michael P.; Cole, B. Eliot; Fishbain, David A.; Irving, Gordon A.; McCarberg, Bill H.; McLean, Michael J.
April 2006
Mayo Clinic Proceedings;Apr2006 Supplement, Vol. 81 Issue 4, pS12
Academic Journal
Despite the number of patients affected by diabetic peripheral neuropathic pain (DPNP), little consensus exists about the pathophysiology, best diagnostic tools, and primary treatment choices. Theories about the causes of DPNP are inextricably linked with the causes of diabetic neuropathies, yet most patients with such neuropathies do not experience pain. The factors that differentiate patients with pain from those without remain unknown and are the subject of much research. When choosing treatment for patients with DPNP, physicians are confronted with a myriad of choices, none of which has been shown to be effective for all patients. This article reviews the evidence for these treatments and attempts to guide physicians in choosing those treatments based on evidence from well-designed clinical trials to support their use. Two agents, duloxetine and pregabalin, are formally approved by the Food and Drug Administration for the treatment of DPNP. In addition, several other agents, including the tricyclic class of antidepressants, have been effective in clinical trials. Ultimately, treatment choice must also include consideration of adverse effects, individual patient factors such as comorbidities, and often cost.


Related Articles

  • Abstract.  // Formulary;Dec2005, Vol. 40 Issue 12, p438 

    An abstract of the article "Pharmacologic options for the management of diabetic peripheral neuropathy," by Mary Gauthier-Lewis, Yasir Ibrahim and Daniel Riche is presented.

  • Diabetic Neuropathy: What You Can Do About It.  // American Family Physician;9/1/1999, Vol. 60 Issue 3, p1000 

    Provides information on diabetic neuropathy. Manifestations of diabetic neuropathy; Clinical definition of diabetic neuropathy; Preventive measures of diabetic neuropathy.

  • 4-g Monofilament Is Clinically Useful for Detecting Diabetic Peripheral Neuropathy. Nagai, Yukihiro; Sugiyama, Yu; Abe, Toshio; Nomura, Gakuji // Diabetes Care;Jan2001, Vol. 24 Issue 1, p183 

    Compares the efficacy of a 4-gram monofilament in detecting early diabetic peripheral neuropathy. Subjects; Sensitivity tests; Comparison with the 10-gram monofilament.

  • The Ipswich Touch Test for Diabetic Peripheral Neuropathy. Kuritzky, Louis // Neurology Alert;Sep2011 Supplement, p18 

    The article discusses research on detection of diabetic neuropathy, with reference to the study "The Ipswich Touch Test for Diabetic Peripheral Neuropathy," by G. Rayman, et al. published in a 2011 issue of "Diabetes Care."

  • Impact of diabetes mellitus duration on effect of lower extremity nerve decompression in 1,526 diabetic peripheral neuropathy patients. Zhong, Wenxiang; Zhang, Wenchuan; Yang, Min; Li, Guowei; Ma, Qiufeng; Yang, Xiaosheng // Acta Neurochirurgica;Jul2014, Vol. 156 Issue 7, p1329 

    Background: Diabetic peripheral neuropathy (DPN) is one of the most common complications of diabetes mellitus (DM). The aim of this study was to analyze DM duration in the prognosis of diabetic peripheral neuropathy of the lower extremity. Methods: A total of 1,526 DPN patients who were treated...

  • Screening for Diabetic Neuropathy Using the NeuroQol. Hermanns, Norbert; Kulzer, Bernd; Stark, Sabine; Haak, Thomas // Diabetes;Jun2007 Supplement 1, Vol. 56, pA497 

    Introduction: Early diagnosis of diabetic neuropathy is important to prevent diabetic foot problems. Diagnosis of diabetic neuropathy requires standardized assessment of neuropathy symptoms as well as clinical examination for sensory deficits. In this study we assessed the screening performance...

  • Identifying common genetic risk factors of diabetic neuropathies. Witzel, Ini-IsabĂ©e; Jelinek, Herbert F.; Khalaf, Kinda; Sungmun Lee; Khandoker, Ahsan H.; Alsafar, Habiba // Frontiers in Endocrinology;May2015, Vol. 6, p1 

    Type 2 diabetes mellitus (T2DM) is a global public health problem of epidemic proportions, with 60-70% of affected individuals suffering from associated neurovascular complications that act on multiple organ systems. The most common and clinically significant neuropathies of T2DM include uremic...

  • Is there such a thing as mild diabetes? Davidson, Jaime A.; Bressler, Peter E. // Patient Care;2/15/1995, Vol. 29 Issue 3, p130 

    Comments on the case of a diabetic man with retinopathy and neuropathy. Results of physical examinations; Treatment; Need for regular eye and neurologic examinations for diabetic patients.

  • Controlling Diabetic Neuropathic Pain. Rubin, Michael // Neurology Alert;Nov2012, Vol. 31 Issue 3, preceding p18 

    Among the 246 million diabetics worldwide, approximately 20-30 million are at risk for polyneuropathy. More than 80% of patients with diabetic polyneuropathy have the distal, symmetric form, which is painful in 16%, unreported in 12.5%, and untreated in 39%. Relief is desperately sought. Which...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics